• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Amgen Gaps Higher on Mixed Numbers, Share Buyback

Let's review the charts and indicators.
By BRUCE KAMICH
Feb 08, 2022 | 01:54 PM EST
Stocks quotes in this article: AMGN

Amgen (AMGN) is known for its work in human therapeutics. Historically, some of Amgen's most successful drugs have been used to treat low white blood cell counts, osteoporosis, and colorectal cancer. Personally, I am getting to the age when I may have to start thinking about researching some of them.

 
The biotechnology firm reported their quarterly numbers after the close of trading Monday. The company beat EPS estimates but missed on revenue. A $6 billion share buyback is planned for Q1 and AMGN gapped higher Tuesday.
 
Let's look at the charts. In our review of December 30 we wrote that " This current rally in AMGN could surprise on the upside. Add to longs at current levels and consider buying more on a close above the 200-day line. Raise stops to $215."
 
In this updated daily bar chart of AMGN, below, we can see that prices stayed above our $215 stop point and gapped higher today. AMGN has made a new high for the move up and trading volume has been increasing since the beginning of the year. AMGN is trading above the rising 50-day average line and gapped above the 200-day line.
 
The daily On-Balance-Volume (OBV) line dipped in January but is starting to rise again. The Moving Average Convergence Divergence (MACD) oscillator has narrowed and is poised to cross to the upside for a new buy signal.
 
 
In this weekly Japanese candlestick chart of AMGN, below, we do not have the current price movement plotted as this charting service waits until Friday to update their free charts. We can imagine that prices are trading above the 40-week average line.
 
The weekly OBV line is moving in the right direction and the MACD oscillator is close to crossing above the zero line.
 
 
In this daily Point and Figure chart of AMGN, below, we can see a $299 price target. Let's call it $300.
 
 
Bottom line strategy: AMGN may encounter some selling resistance in the $245-$260 area which could slow or stunt the current advance. Traders should raise stops to $225 from $215. Carryover buying in the days ahead will be encouraging.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Earnings | Investing | Stocks | Technical Analysis | Trading | Biotechnology

More from Investing

Market Meanders Into Nowhere

Helene Meisler
Jul 7, 2022 6:00 AM EDT

We're in a chop-fest, and not only are stocks stuck in either/or mode, so are the indicators.

This Is No Market for Commitment

James "Rev Shark" DePorre
Jul 6, 2022 4:55 PM EDT

After Tuesday's rotational moves, Wednesday was choppy. Here's why this is not a time to make long-term trades.

This Won't Hurt a Bit: Moderna Could Rally 25% From Here

Bruce Kamich
Jul 6, 2022 2:59 PM EDT

The stock is ready to make a recovery rally.

Can You Spot a Rally Coming for Spotify?

Bruce Kamich
Jul 6, 2022 1:26 PM EDT

Let's see where investors can go long on SPOT, according to my read of the charts.

Move Over Minnie, I've Got a Love-Hate Relationship With Disney

Stephen Guilfoyle
Jul 6, 2022 1:00 PM EDT

DIS has been no day in the park for investors -- in fact, it's been acting more than a little Goofy lately. But I see this ride down starting to turn.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:01 PM EDT PAUL PRICE

    A Recent Director Buy in Children's Place (PLCE)

    Four of the most recent insider trades in Children...
  • 07:34 AM EDT PAUL PRICE

    A $525,000 Vote of Confidence on Macerich (MAC)

  • 09:49 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Stop Wishing, Hoping, and Praying and Take Control...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login